The Clinton Health Access Initiative (CHAI) published the Advanced HIV Disease (AHD) Impact Report, which provides a detailed look at progress made since 2019 to avert preventable deaths among people with AHD, best practices for AHD program implementation, and CHAI’s perspective of what more will be needed to effectively end deaths from AHD-related opportunistic infections.

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).

28 July 2022 | Geneva -- Over 130 participants from countries, civil society, affected communities, partners and the private sector joined a virtual consultation organized by WHO’s Global TB Programme on the development of guidance for conducting reviews of TB programmes.

The International Journal of Tuberculosis and Lung Disease (IJTLD) published the first four Clinical Standards for Lung Health.

SA’s progress in expanding access to PrEP is one of the few positive findings in the latest global AIDS report.

India has the highest number of multidrug-resistant TB cases in the world, contributing a quarter of the global burden, and Mumbai is a hot spot. Old building codes regulating light and space have ceased to exist in the city. In an increasingly interconnected modern world, with pandemics and antibiotic resistance on the rise, experts now worry that this architectural amnesia may prove devastating.

Rapid point-of-care tests could diagnose infected patients before they become severely ill and spread tuberculosis to others.

26 July 2022 | Geneva -- Over 300 representatives from countries and partners joined the webinar on “Strengthening TB surveillance: supporting countries to transition to case-based, digital surveillance”.

Analysis of nearly 23 million lab tests finds only 1 in 3 patients with latent tuberculosis were also tested for chronic hepatitis B, despite similar risk factors in patients

Findings heighten caution about use of tuberculosis therapies, which raise risk of liver injury in patients co-infected with chronic hepatitis B virus

Resistance to tuberculosis drugs has become a major threat to the control of the disease globally.